Community corner

    Article metrics

    • An Erratum to this article was published on 01 July 2008

    Access options

    Rent or Buy article

    Get time limited or full article access on ReadCube.


    All prices are NET prices.


    1. 1

      Kleinman, M.E., Yamada, Y. et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591–597 (2008).

    Download references

    Ethics declarations

    Competing interests

    P.D.Z. is a cofounder and scientific advisor to Alnylam Pharmaceuticals and a scientific advisor to Regulus Therapeutics.

    Rights and permissions

    Reprints and Permissions

    About this article

    Further reading